Related by context. Frequent words. (Click for all words.) 76 Meets Primary Endpoint 74 Phase III Clinical Trial 74 Patient Enrollment 74 Receives Orphan Drug Designation 73 Generic Version 73 Kuvan R 73 Release Tablets 72 Phase III Trial 72 Pivotal Phase III 71 FDA Accepts 71 Single Dose 71 Aloxi R 71 Pulmonary Arterial Hypertension 71 Presents Positive 70 ABILIFY R 70 refractory chronic lymphocytic 70 Drug Candidate 70 Ranexa R 70 Ambrisentan 70 Extended Release 70 Lubiprostone 70 Initiates Phase II 70 Cetrorelix 69 Clinical Trial Results 69 Completes Enrollment 69 Pivotal Phase 69 Delayed Release 69 ZALBIN 69 BioGlue R 69 pseudobulbar affect PBA 69 R sorafenib tablets 68 Oral Solution 68 THALOMID 68 Pirfenidone 68 Stavzor 68 Copegus R 68 R bortezomib 68 Extended Release Tablets 68 Pivotal Trial 68 Panzem R 68 Positive Opinion 68 Sapacitabine 68 Xyntha 68 ACTIQ 68 Transcept Pharmaceuticals 67 Ventavis 67 REVLIMID R 67 Frova R 67 ZEGERID Capsules 67 Diabetic Macular Edema 67 Wellbutrin XL R 67 ELADUR 67 Recombinant Human 67 Application MAA 67 Icatibant 67 MKC# 67 Surgical Adhesive 67 PRISTIQ 67 Inc Therapeutic Competitors 67 Ticagrelor 67 Aradigm Corporation 67 Application BLA 67 Acetate Rectal Suppositories 67 Testim R 67 forodesine 66 AMRIX 66 Initiate Phase 66 Significantly Improves 66 Gemzar ® 66 Significantly Improved 66 Ixempra 66 NEBIDO R 66 OPANA ER 66 VALSTAR 66 AMITIZA R 66 Valsartan 66 Oral Suspension Oral Suspension 66 alvimopan 66 Coadministration 66 Osteoporosis Drug 66 RNAi Therapeutics 66 ATryn ® 66 * Azixa 66 Eltrombopag 66 Full Prescribing Information 66 Preclinical Data 66 gets USFDA nod 65 Metastatic Melanoma 65 Anika Therapeutics 65 RISPERDAL ® CONSTA ® 65 Argatroban 65 Topiramate 65 Eloxatin ® 65 injection USP 65 Therapeutic Competitors 65 6R BH4 65 Entereg R 65 Azilect ® 65 DDP# 65 Cinryze TM 65 TYGACIL